Kyowa Kirin Co., Ltd. Grants Knight Exclusive LATAM Rights for Mogamulizumab

Kyowa Kirin signed an exclusive distribution agreement with Knight Therapeutics for mogamulizumab in Argentina, Brazil, Colombia and Mexico. Knight will seek regulatory approvals and commercialize the drug for MF and Sézary syndrome.Material DetailsContext by AI AnalystThis is an early-stage geogra…